<DOC>
	<DOCNO>NCT02071381</DOCNO>
	<brief_summary>The purpose study evaluate drug interaction compare pharmacokinetics group monotherapy DW330SR , monotherapy DW1030 , coadministration DW330SR DW1030</brief_summary>
	<brief_title>Phase 1 Study DDI Between DW330SR DW1030 Healthy Male Subjects</brief_title>
	<detailed_description />
	<criteria>Healthy Adult male age 20~40 year screen visit Subjects range 19 kg/m2 ~ 27 kg/m2 BMI measurement screen visit Subjects BP range : 90 mmHg ≤ Systolic BP ≤ 140 mmHg 50 mmHg ≤ Diastolic BP ≤ 90mmHg Subjects voluntarily agree write consent able understand objective , method study , characteristic investigational drug , comply reguirement study Subjects clinically significant disease history Liver , kidney , gastrointestinal , respiratory , musculoskeletal , endocrine , nervous psychiatric , blood tumor system cardiovascular . ( In particular , bronchial asthma , severe hepatic , renal failure , severe blood disorder , severe myasthenia gravis , cardiac dysfunction , peptic ulcer , etc . ) Subjects history gastrointestinal disease ( ex , Chrones dz , peptic ulcer , etc ) affect absorption Investigational drug history surgery ( except simple appendectomy hernia surgery ) Subjects hypersensitivity reaction clinically significant disease drug ( Aspirin , NSAID antibiotic ) include ingredient DW330SR DW1030 Food</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>January 2014</verification_date>
</DOC>